Paul Choi
Stock Analyst at Goldman Sachs
(3.53)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AMRN Amarin Corp | Maintains: Sell | 7 12 | 15.22 | -21.16% | 8 | Jun 25, 2025 | |
URGN UroGen Pharma | Maintains: Neutral | 16 3 | 20.69 | -85.5% | 4 | May 22, 2025 | |
GOSS Gossamer Bio | Maintains: Strong Buy | 7 8 | 2.77 | 188.81% | 6 | May 16, 2025 | |
PHAT Phathom Pharmaceutic... | Maintains: Neutral | 10 5 | 12.89 | -61.21% | 10 | May 2, 2025 | |
ARVN Arvinas | Maintains: Neutral | 12 8 | 8 | 0% | 3 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 52 | 37.51 | 38.63% | 2 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 5.24 | 300.76% | 8 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 12 | 9.89 | 21.33% | 3 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 2.54 | 18.11% | 9 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 12 10 | 9.92 | 0.81% | 4 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 225 | 202.91 | 10.89% | 4 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 143 | 55.07 | 159.67% | 1 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 42 | 58.42 | -28.11% | 7 | Dec 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 85 60 | 51.5 | 16.5% | 2 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 19 | 16.05 | 18.38% | 6 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 32 | 36.86 | -13.19% | 1 | Jul 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 29 50 | 53.5 | -6.54% | 6 | Jul 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 5.43 | 249.91% | 3 | Jun 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 400 50 | 11.48 | 335.54% | 7 | Jun 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 29 26 | 2.65 | 881.13% | 2 | Apr 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 4 | 1.54 | 159.74% | 1 | Oct 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 25 | 1.6 | 1462.5% | 3 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 100 | n/a | n/a | 3 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 4 | n/a | n/a | 4 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 4 | 5.87 | -40.37% | 1 | Apr 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 151 170 | 14.49 | 1073.22% | 2 | Oct 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 225 125 | n/a | n/a | 2 | Sep 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 9 8 | 4.71 | 69.85% | 4 | Aug 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 132 | n/a | n/a | 3 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 33 | 30 | 10% | 1 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 112 | 46.99 | 138.35% | 1 | Mar 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 30 | 26.98 | 11.19% | 1 | Jan 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | n/a | n/a | 1 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 48 49 | n/a | n/a | 4 | Jul 15, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 91 103 | n/a | n/a | 2 | Jul 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 135 | 144.17 | -6.36% | 1 | Jun 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 240 | 0.7 | 34185.71% | 2 | Jun 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 5 22 | n/a | n/a | 3 | Apr 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 270 300 | 48.57 | 517.67% | 2 | Mar 30, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 40 | n/a | n/a | 3 | Oct 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 56 | n/a | n/a | 3 | Aug 6, 2018 |